80th Anniversary: May & Baker To Unveil State-Of-The-Art Bio-Vaccine Factory, Loxaclam Antibiotic

In a significant milestone marking its Octogintennial – 80th anniversary, pharmaceutical giant May & Baker Nigeria Plc has announced plans to unveil a state-of-the-art bio-vaccine factory and introduce Loxaclam, a new antibiotic, on Tuesday, being its commitment to advancing healthcare. Additionally, May & Baker will commercialise Roveda, a bitter leaf capsule, further expanding its product [...]

Read More